2009年国际妇产科联盟（FIGO）的分期系统对Ⅰ期子宫内膜癌真的有价值吗？

Is the 2009 FIGO staging system really valuable for stage I endometrial cancer?

作者信息

Atalay F, Cetinkaya K, Bacinoglu A

机构信息

Department of Obstetrics and Gynecology, Ankara Oncology Education and Research Hospital, Ankara, Turkey.

出版信息

Eur J Gynaecol Oncol. 2013;34(6):556-8.

PMID:24601051

Abstract

PURPOSE

The aim of this study was to compare the survival predictive values of the 1988 and 2009 FIGO staging systems for the staging of patients with early-stage endometrioid type endometrial cancer.

MATERIALS AND METHODS

Two hundred twenty-four patients treated for endometrial cancer from 1996 to 2006 at Ankara Oncology Education and Research Hospital were staged according to the two staging systems. Early-stage patients with a histological diagnosis of endometrioid adenocarcinoma were included in the study. The Kaplan-Meier method was used for survival analysis.

RESULTS

The charts of 224 patients treated for endometrial cancer were retrospectively evaluated. The five-year overall survival (OS) for Stage IA and IB cases was 100% (n = 19) and 96.2% (n = 79), respectively, with no significant difference between the OS values (p = 0.126) with the FIGO 1988 system and 96,4% (n = 112) and 87.5% (n = 48), respectively with a statistically significant difference (p = 0.05) with the FIGO 2009 system.

CONCLUSION

The authors found that the survival prognostic value of the 2009 FIGO staging system was more effective than the 1988 FIGO staging system for cases with early-stage endometrioid type endometrial cancer.

摘要

目的

本研究旨在比较1988年和2009年国际妇产科联盟（FIGO）分期系统对早期子宫内膜样型子宫内膜癌患者分期的生存预测价值。

材料与方法

对1996年至2006年在安卡拉肿瘤学教育与研究医院接受子宫内膜癌治疗的224例患者按照这两种分期系统进行分期。纳入组织学诊断为子宫内膜样腺癌的早期患者。采用Kaplan-Meier法进行生存分析。

结果

对224例接受子宫内膜癌治疗患者的病历进行回顾性评估。按照1988年FIGO系统，IA期和IB期病例的五年总生存率（OS）分别为100%（n = 19）和96.2%（n = 79），OS值之间无显著差异（p = 0.126）；按照2009年FIGO系统，分别为96.4%（n = 112）和87.5%（n = 48），差异有统计学意义（p = 0.05）。